A new survey from The Mesothelioma Center at Asbestos.com highlights growing selectivity in surgical recommendations while keeping surgery on the table for certain pleural mesothelioma patients.
Cyncado is using these findings to finalize clinical development plans for TT-4 in mesothelioma, with first patient dosing on track for Q1 2026.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback